INVITRO EFFECTS OF FOLATE INHIBITORS ON TOXOPLASMA-GONDII

被引:73
作者
DEROUIN, F [1 ]
CHASTANG, C [1 ]
机构
[1] HOP ST LOUIS,DEPT BIOSTAT & INFORMAT MED,F-75475 PARIS 10,FRANCE
关键词
D O I
10.1128/AAC.33.10.1753
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
引用
收藏
页码:1753 / 1759
页数:7
相关论文
共 27 条
[21]   BIOAVAILABILITY OF ORAL TRIMETREXATE IN PATIENTS WITH ACQUIRED IMMUNODEFICIENCY SYNDROME [J].
ROGERS, P ;
ALLEGRA, CJ ;
MURPHY, RF ;
DRAKE, JC ;
MASUR, H ;
POPLACK, DG ;
CHABNER, BA ;
PARRILLO, JE ;
LANE, HC ;
BALIS, FM .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1988, 32 (03) :324-326
[22]  
Sabin AB, 1942, P SOC EXP BIOL MED, V51, P19, DOI 10.3181/00379727-51-13809
[23]  
Scheffe H., 1999, ANAL VARIANCE, V72
[24]   EFFECT OF PYRIMETHAMINE AND SULFADIAZINE ON FINE-STRUCTURE AND MULTIPLICATION OF TOXOPLASMA-GONDII IN CELL-CULTURES [J].
SHEFFIELD, HG ;
MELTON, ML .
JOURNAL OF PARASITOLOGY, 1975, 61 (04) :704-712
[25]  
WEIDEKAMM E, 1982, B WORLD HEALTH ORGAN, V60, P115
[26]   PYRIMETHAMINE CONCENTRATIONS IN SERUM AND CEREBROSPINAL-FLUID DURING TREATMENT OF ACUTE TOXOPLASMA ENCEPHALITIS IN PATIENTS WITH AIDS [J].
WEISS, LM ;
HARRIS, C ;
BERGER, M ;
TANOWITZ, HB ;
WITTNER, M .
JOURNAL OF INFECTIOUS DISEASES, 1988, 157 (03) :580-583
[27]  
ZINNER SH, 1985, PRINCIPLES PRACTICE, P237